Receptor BioLogix, Inc. is a biopharmaceutical company focused on the discovery and development of proprietary biotherapeutics designed to modulate the receptor tyrosine kinase (RTK) family of cell-surface receptors. These receptors are involved in most cancers and many other diseases.

L A T E S T   N E W S :
Pioneers of Targeted Breast Cancer Therapy Win Nineteenth Annual Warren Alpert Foundation Prize. 5/30/07 READ >>